Afluria 33332-0025-03
Generic: Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (propiolactone Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (propiolactone Inactivated)
- Manufacturer
- Seqirus Pty Ltd.
- Dosage Form
- Injection, Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- July 1, 2025
- Application
- BLA125254
Active Ingredients
| Ingredient | Strength |
|---|---|
| Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (propiolactone Inactivated) | 15 ug/.5mL |
| Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (propiolactone Inactivated) | 15 ug/.5mL |
| Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (propiolactone Inactivated) | 15 ug/.5mL |
Selected Package
33332-0025-03Selected10 SYRINGE, GLASS in 1 CARTON (33332-025-03) / .5 mL in 1 SYRINGE, GLASS (33332-025-04)
External Resources